Table 2.
Pooled genotypic effects of SLCO1B1 gene rs4149056 polymorphisms in Caucasian with specific type of statin.
Study | Author | Year | Myopathy | Control | CC vs TT | TC vs TT | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of subjects in case | Genotype | No. of subjects in control | Genotype | OR1 | 95% CI | OR2 | 95% CI | |||||||||
TT | TC | CC | TT | TC | CC | |||||||||||
Caucasian with statin users | ||||||||||||||||
1 | Willrich et al. [38] | 2018 | 89 | 67 | 21 | 1 | 89 | 57 | 30 | 2 | 0.43 | 0.04, 4.81 | 0.60 | 0.31, 1.15 | ||
2 | Bakar et al. [39] | 2017 | 125 | 78 | 45 | 2 | 476 | 353 | 112 | 11 | 0.82 | 0.18, 3.79 | 1.82 | 1.19, 2.78 | ||
3 | Mirošević Skvrce et al. [40] | 2015 | 60 | 34 | 22 | 4 | 90 | 69 | 21 | 0 | 18.13 | 0.95, 346.44 | 2.13 | 1.03, 4.39 | ||
4 | Ferrari et al. [41] | 2014 | 33 | 8 | 13 | 12 | 33 | 18 | 13 | 2 | 13.50 | 2.43,74.87 | 2.25 | 0.72, 6.99 | ||
5 | Carr et al. [26] | 2013 | 76 | 40 | 30 | 6 | 372 | 260 | 101 | 11 | 3.55 | 1.24, 10.12 | 1.93 | 1.14, 3.27 | ||
6 | Brunham et al. [42] | 2012 | 25 | 15 | 8 | 2 | 83 | 57 | 20 | 6 | 1.27 | 0.23, 6.92 | 1.52 | 0.56, 4.12 | ||
7 | Donnelly et al. [17] | 2011 | 816 | 565 | 227 | 24 | 1275 | 905 | 348 | 22 | 1.75 | 0.97, 3.15 | 1.04 | 0.86, 1.27 | ||
8 | Linde et al. [44] | 2010 | 27 | 14 | 12 | 1 | 19 | 15 | 4 | 0 | 3.21 | 0.12, 85.20 | 3.21 | 0.84, 12.35 | ||
9 | Voora et al. [45] | 2009 | 97 | 62 | 31 | 4 | 351 | 263 | 84 | 4 | 4.24 | 1.03, 17.43 | 1.57 | 0.95, 2.57 | ||
10 | Link et al. [18] | 2008 | 85 | 29 | 35 | 21 | 90 | 70 | 17 | 3 | 16.9 | 4.68, 61.06 | 4.97 | 2.41, 10.24 | ||
Pooled | 2.92 | (1.59, 5.34) | 1.61 | (1.20, 2.16) | ||||||||||||
Caucasian with atorvastatin users | ||||||||||||||||
1 | Mirošević Skvrce et al. [40] | 2015 | 60 | 34 | 22 | 4 | 90 | 69 | 21 | 0 | 18.13 | 0.95, 346.44 | 2.13 | 1.03, 4.39 | ||
2 | Carr et al. [26] | 2013 | 11 | 7 | 4 | 0 | 110 | 86 | 22 | 2 | 2.31 | 0.10, 52.59 | 2.23 | 0.60, 8.32 | ||
3 | Brunham et al. [42] | 2012 | 10 | 7 | 2 | 1 | 34 | 24 | 7 | 3 | 1.14 | 0.10, 12.78 | 0.98 | 0.16, 5.83 | ||
Pooled | 3.95 | (1.23, 12.63) | 1.98 | (1.11, 3.52) | ||||||||||||
Caucasian with simvastatin users | ||||||||||||||||
1 | Bakar et al. [39] | 2017 | 125 | 78 | 45 | 2 | 476 | 353 | 112 | 11 | 0.82 | 0.18, 3.79 | 1.82 | 1.19, 2.78 | ||
2 | Carr et al. [26] | 2013 | 59 | 29 | 25 | 5 | 222 | 147 | 71 | 4 | 6.34 | 1.60, 25.03 | 1.78 | 0.97, 3.27 | ||
3 | Brunham et al. [42] | 2012 | 12 | 5 | 6 | 1 | 39 | 27 | 10 | 2 | 2.70 | 0.20, 35.75 | 3.24 | 0.81, 13.02 | ||
4 | Donnelly et al. [17] | 2011 | 816 | 565 | 227 | 24 | 1275 | 905 | 348 | 22 | 1.75 | 0.97, 3.15 | 1.04 | 0.86, 1.27 | ||
5 | Link et al. [18] | 2008 | 85 | 29 | 35 | 21 | 90 | 70 | 17 | 3 | 16.90 | 4.68, 61.06 | 4.97 | 2.41, 10.24 | ||
Pooled | 2.81 | (1.17, 6.77) | 1.78 | (1.15, 2.77) |
CI confidence interval, OR odds ratio.